证券代码：601211 证券简称：国泰海通 公告编号：2026-005 国泰海通证券股份有限公司 关于计提资产减值准备的公告 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 根据《企业会计准则》和国泰海通证券股份有限公司（以下简称公司）会计政策的相关规定，公司及下 属子公司对截至2025年12月31日的各项需要计提减值的资产进行了初步预期信用损失评估和减值测试， 现将具体情况公告如下： 一、计提资产减值准备情况概述 经初步评估，公司2025年10-12月计提信用减值损失人民币160,397万元，计提其他资产减值损失人民币 2,582万元，合计计提资产减值损失人民币162,979万元，对净利润的影响超过公司2024年度经审计的净 利润的10%。 单位：人民币万元 ■ 注1：本年新增计提长期应收款、应收融资租赁款信用减值损失(同时新增长期应收款利息收入、融资租 赁收入)，主要是吸收合并海通证券股份有限公司（以下简称海通证券）新增租赁业务。租赁业务的盈 利模式 ...

Group 1 - The company plans to recognize an impairment provision of 175.7388 million yuan for the year 2025, which will reduce the total profit of the consolidated financial statements by the same amount [2][8] - The impairment provision is based on a comprehensive review and assessment of the company's assets as of December 31, 2025, in accordance with accounting standards [2][8] - The total impairment provisions include 37.334 million yuan for receivables, 0.0778 million yuan for other financial assets, and 16.2298 million yuan for inventory and contract fulfillment costs [3][4][5] Group 2 - The company expects to achieve a net profit attributable to shareholders of the parent company between 2.3 billion yuan and 2.75 billion yuan for the year 2025, representing an increase of 725.75 million yuan to 1.17575 billion yuan compared to the previous year [15][17] - The expected net profit, excluding non-recurring gains and losses, is projected to be between 2.25 billion yuan and 2.7 billion yuan, with a similar increase compared to the previous year [15][17] - The growth in profit is attributed to strong governance, quality improvement, risk control, and the stable growth of the main business, along with significant increases in investment income and fair value changes from the financial sector [21]

Core Viewpoint - Beijing International Human Capital Group Co., Ltd. anticipates a significant increase in its 2025 annual performance, projecting a net profit rise of over 50% compared to the previous year [2][4]. Performance Forecast - The company estimates a net profit attributable to shareholders for 2025 to be between 1,050 million yuan and 1,300 million yuan, representing an increase of 258.6 million yuan to 508.6 million yuan, which corresponds to a year-on-year growth of 32.68% to 64.26% [2][4]. - The projected net profit, excluding non-recurring gains and losses, is expected to be between 540 million yuan and 600 million yuan, with an increase of 6.54 million yuan to 66.54 million yuan [2][4]. Previous Year’s Performance - In the previous year, the total profit was 1,345.3667 million yuan, with a net profit attributable to shareholders of 791.4048 million yuan, and a net profit excluding non-recurring items of 533.4606 million yuan [6]. Reasons for Performance Increase - The growth in performance is attributed to the company's focus on core business development, enhanced customer acquisition and maintenance, and continuous optimization of cost management, which has improved operational efficiency [8]. - Additionally, the sale of a wholly-owned subsidiary, Beijing Urban and Rural Huangsi Commercial Building Co., Ltd., in the first quarter of 2025 contributed significant non-recurring gains, positively impacting the net profit attributable to shareholders [8].

一、本期业绩预告情况 （一）业绩预告期间 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 证券代码：600958 证券简称：东方证券 公告编号：2026-003 东方证券股份有限公司 2025年年度业绩预增公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： 1.业绩预告的具体适用情形：实现盈利，且净利润与上年同期相比上升50%以上。 2.东方证券股份有限公司（以下简称"公司"）预计2025年年度实现营业收入人民币153.4亿元，归属于母 公司所有者的净利润人民币56.2亿元，归属于母公司所有者的扣除非经常性损益的净利润人民币55.0亿 元。 2025年1月1日至2025年12月31日。 （二）业绩预告情况 经财务部门初步测算，公司2025年的经营业绩和财务状况如下： 1.预计2025年年度实现营业收入人民币153.4亿元，与上年同期相比，将增加人民币31.7亿元，同比增加 26.0%。（收入追溯情况说明：财政部于2025年7月8日发布标准仓单交易相关会计处理实施问答（以下 简称"问答 ...

交易信息汇总资金流向 截至2026年1月27日收盘，大博医疗(002901)报收于51.9元，上涨7.45%，换手率2.51%，成交量7.24万 手，成交额3.71亿元。 当日关注点 大博医疗科技股份有限公司发布2025年度业绩预告，预计归属于上市公司股东的净利润为58,000万元至 61,000万元，同比增长62.55%至70.96%；扣除非经常性损益后的净利润为45,500万元至48,500万元，同 比增长59.42%至69.93%。基本每股收益为1.43元/股至1.50元/股。业绩增长主要得益于公司聚焦主业、 推进产品创新和国际化战略。该数据为财务部门初步测算结果，未经审计，最终以2025年年度报告为 准。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 来自交易信息汇总：1月27日主力资金净流入1299.83万元，呈现明显吸筹迹象。 来自公司公告汇总：大博医疗预计2025年净利润同比增长62.55%至70.96%，业绩大幅预增。 1月27日主力资金净流入1299.83万元；游资资金净流出987.92万元；散户资金净流出311 ...

| જેટ મેતિ | 公司 | 主要内容 | | --- | --- | --- | | 聚焦 | 臺韋点 | 筹划控制权变更事项 28日起停牌 | | | 万科A | 深铁集团向公司提供不超过23.6亿元借款 | | | 东材科技 | 实控人、副董事长熊海涛被留置 | | | 国泰海通等 | 业绩预增 | | | 多家券商 | | | | 康希诺 | 预计2025年净利润2450万元-2900万元 同比 扭亏为盈 | | | 何氏眼科 | 2025年度预盈2400万至3600万元 同比扭亏 | | | 常山北明 | 2025年度预盈3500万元 同比扭亏 | | | 国盾量子 | 预计2025年净利润500万元左右 同比扭亏为盈 | | | 宁波富邦 | 2025年净利润同比预增3099.59%-4379.43% | | | 金马游乐 | 2025年净利润同比预增811.17%-1069.56% | | | 怡球资源 | 2025年净利润同比预增620%-970% | | | 臻雷科技 | 2025年净利润同比预增530%-642% | | 业绩精选 | 英图川醋 | 2025年净利润同比预增428.3 ...

Core Viewpoint - The agricultural chemical industry is experiencing significant growth, with multiple companies reporting substantial increases in earnings for the year 2025, driven by rising product prices and improved operational efficiencies [1][2][3]. Group 1: Company Performance - Xinda Co. expects a net profit of 135 million to 155 million yuan for 2025, a turnaround from a loss of 25.87 million yuan in the previous year [1]. - Lier Chemical reported an estimated revenue of approximately 9.008 billion yuan for 2025, a year-on-year increase of 23.21%, with a net profit of about 479 million yuan, up 122.33% [2]. - Limin Co. anticipates a net profit of 465 million to 500 million yuan for 2025, representing a year-on-year growth of 471.55% to 514.57% [2]. - Dongfang Tieta expects a net profit of 1.08 billion to 1.27 billion yuan for 2025, reflecting a growth of 91.40% to 125.07% compared to the previous year [3]. Group 2: Industry Trends - The agricultural chemical sector is seeing a positive trend, with 20 listed companies having disclosed earnings forecasts, of which 10 are expected to see profit increases and 2 are expected to turn losses into profits [1]. - The recent policy changes regarding export tax rebates for agricultural chemicals are anticipated to boost industry sentiment, as companies may increase prices to maintain profitability amid rising export costs [4][5]. - The cancellation of export tax rebates is expected to lead to higher costs for exporters, prompting them to raise prices, which could support both volume and price increases in the agricultural chemical market [5].

智通财经APP讯，华西证券(002926.SZ)发布2025年度业绩预告，预计全年实现归属于上市公司股东的净 利润12.7亿元至16.5亿元，同比增长74.46%-126.66%。 2025年，我国资本市场整体呈现上行态势，投资者信心持续回暖，市场交投活跃度显著提升。公司积极 把握市场机遇，稳中求进，推动财富管理业务和投资业务均实现较高增长，经营业绩稳步提升。 ...

柳工（000528）(000528.SZ)披露2025 年年度业绩预告 ，公司预计归属于上市公司股东的净利润15.26亿 元至16.59亿元，同比增长15%–25%;归属于上市公司股东扣除非经常性损益的净利润13.23亿元至14.55 亿元，同比增长16%–28%。 ...

Group 1 - The company Zhongtong Bus (000957.SZ) has disclosed its earnings forecast for the year 2025, expecting a net profit attributable to shareholders of between 320 million yuan and 410 million yuan, representing a year-on-year growth of 28.28% to 64.36% [1] - The net profit after deducting non-recurring gains and losses is projected to be between 290 million yuan and 380 million yuan, indicating a year-on-year increase of 35.47% to 77.52% [1]